Cardiovascular risk and all-cause mortality attributable to diabetes: Tehran Lipid and Glucose Study

被引:0
|
作者
M. Bozorgmanesh
F. Hadaegh
F. Sheikholeslami
F. Azizi
机构
[1] Shahid Beheshti University of Medical Sciences,Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences
关键词
All-cause mortality; cardiovascular disease; diabetes; population attributable fraction; risk;
D O I
暂无
中图分类号
学科分类号
摘要
Aim: To quantify the burden of cardiovascular diseases (CVD), and all-cause mortality attributable to diabetes. Subjects and methods: Data on an 8.6-yr follow-up of 6331 participants (2741 men), free of CVD at baseline, were analyzed to determine the burden of CVD and all-cause mortality attributable to self-reported and screen-detected diabetes mellitus (SRDM and SDDM, respectively). Risks of events of interest were separately assessed for women and men using Cox-proportional-hazard model. Results: The mean age at baseline was 47 yr with 997 (15.7%) of participants having diabetes (men 14.8%, women 16.5%). SRDM and SDDM prevailed in 9.7% (men 9.2, women 10.2%) and 6.0% of participants (men 5.7, women 6.3%), respectively. During follow up (52,404 person-yr), we observed 447 incident cases of CVD [387 had coronary heart disease (CHD)] and 209 deaths. Among men, participants with SDDM had increased relative hazard for all-cause mortality translated to a population attributable risk fraction (PAF) of 10.1%. Among women, SDDM was associated with CVD and CHD but not with all-cause mortality; so that 9.3% and 8.8% of CVD and CHD events were respectively attributable to the SDDM. If SRDM had been eliminated from the population, the incidences of CVD, CHD, and death would have decreased by 10.5, 9.5, and 17.3% in men; and 22.0, 24.2, and 17.8% in women, respectively. Conclusion: SDDM and SRDM have high PAF for all-cause mortality and CVD. Besides diabetes treatment and prevention, screening to detect undiagnosed diabetes should warrant high priority among the public health strategies to lower the incidence of CVD and mortality.
引用
收藏
页码:14 / 20
页数:6
相关论文
共 50 条
  • [1] Cardiovascular risk and all-cause mortality attributable to diabetes: Tehran Lipid and Glucose Study
    Bozorgmanesh, M.
    Hadaegh, F.
    Sheikholeslami, F.
    Azizi, F.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2012, 35 (01) : 14 - 20
  • [2] Risk of all-cause mortality in abdominal obesity phenotypes: Tehran Lipid and Glucose Study
    Doustmohamadian, S.
    Serahati, S.
    Barzin, M.
    Keihani, S.
    Azizi, F.
    Hosseinpanah, F.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2017, 27 (03) : 241 - 248
  • [3] The predictive value of metabolic syndrome for cardiovascular and all-cause mortality: Tehran Lipid and Glucose Study
    Amouzegar, Atieh
    Mehran, Ladan
    Hasheminia, Mitra
    Rahimabad, Parnian Kheirkhah
    Azizi, Fereidoun
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33 (01)
  • [4] Long-term glucose variability and incident cardiovascular diseases and all-cause mortality events in subjects with and without diabetes: Tehran Lipid and Glucose Study
    Barzegar, Niloofar
    Ramezankhani, Azra
    Tohidi, Maryam
    Azizi, Fereidoun
    Hadaegh, Farzad
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 178
  • [5] Ideal cardiovascular health status and risk of cardiovascular disease and all-cause mortality: over a decade of follow-up in the Tehran lipid and glucose study
    Hadaegh, Farzad
    Hosseinpour-Niazi, Somayeh
    Deravi, Niloofar
    Hasheminia, Mitra
    Moslehi, Nazanin
    Toreyhi, Hossein
    Azizi, Fereidoun
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [6] Serum alkaline phosphatase and the risk of coronary heart disease, stroke and all-cause mortality: Tehran Lipid and Glucose Study
    Kabootari, Maryam
    Raee, Mohammad Reza
    Akbarpour, Samaneh
    Asgari, Samaneh
    Azizi, Fereidoun
    Hadaegh, Farzad
    BMJ OPEN, 2018, 8 (11):
  • [7] New-onset diabetes and risk of all-cause and cardiovascular mortality - The cardiovascular health study
    Smith, Nicholas L.
    Lumley, Thomas
    Barzilay, Joshua I.
    Enquobahrie, Daniel
    Kronmal, Richard
    Psaty, Bruce M.
    DIABETES CARE, 2006, 29 (09) : 2012 - 2017
  • [8] Risk Factors for Incidence of Cardiovascular Diseases and All-Cause Mortality in a Middle Eastern Population over a Decade Follow-up: Tehran Lipid and Glucose Study
    Sardarinia, Mahsa
    Akbarpour, Samaneh
    Lotfaliany, Mojtaba
    Bagherzadeh-Khiabani, Farideh
    Bozorgmanesh, Mohammadreza
    Sheikholeslami, Farhad
    Azizi, Fereidoun
    Hadaegh, Farzad
    PLOS ONE, 2016, 11 (12):
  • [9] Shadow of diabetes over cardiovascular disease: comparative quantification of population-attributable all-cause and cardiovascular mortality
    Mohammadreza Bozorgmanesh
    Farzad Hadaegh
    Farhad Sheikholeslami
    Arash Ghanbarian
    Fereidoun Azizi
    Cardiovascular Diabetology, 11
  • [10] Shadow of diabetes over cardiovascular disease: comparative quantification of population-attributable all-cause and cardiovascular mortality
    Bozorgmanesh, Mohammadreza
    Hadaegh, Farzad
    Sheikholeslami, Farhad
    Ghanbarian, Arash
    Azizi, Fereidoun
    CARDIOVASCULAR DIABETOLOGY, 2012, 11